ZEB1: Catalyst of immune escape during tumor metastasis

被引:17
作者
Lu, Jiahui [1 ]
Fei, Fei [1 ]
Wu, Chenxi [1 ]
Mei, Jie [1 ]
Xu, Junying [1 ,2 ]
Lu, Peihua [1 ,2 ]
机构
[1] Nanjing Med Univ, Wuxi Peoples Hosp, Dept Oncol, Wuxi 214023, Peoples R China
[2] Nanjing Med Univ, Wuxi Peoples Hosp, Dept Oncol, 299 Qingyang Rd, Wuxi 214023, Peoples R China
关键词
ZEB1; EMT; Signaling pathway; Metastasis; Tumor immunity; EPITHELIAL-MESENCHYMAL TRANSITION; EMT-ACTIVATOR ZEB1; GRAINYHEAD-LIKE; CANCER-CELLS; ZINC-FINGER; COLORECTAL-CANCER; SIGNALING PATHWAY; DOWN-REGULATION; TARGETING ZEB1; LUNG-CANCER;
D O I
10.1016/j.biopha.2022.113490
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The transcription factor zinc finger E-box binding homeobox 1 (ZEB1) is a critical inducer of epithelial mesenchymal transformation (EMT) and plays a robust role in tumor metastasis. It can promote not only the movement and diffusion of tumor cells but also cell stemness, treatment resistance, tumor metastasis and immune escape. The expression of ZEB1 is strictly regulated by a variety of pretranscriptional and posttranscriptional signaling pathways and molecules. Increasing evidence indicates that protein modifications such as methylation and acetylation of ZEB1 can also affect tumor metastasis. More importantly, ZEB1 induces immunosuppressive cells and chemokines into the tumor microenvironment (TME), leading to the formation of a tumor immunosuppressive microenvironment. This review summarizes the regulatory factors involved in ZEB1 expression and its important role. The areas of research covered in this review contribute to providing new thoughts and new treatment insights for targeted ZEB1 therapy of malignant tumors.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] DPY30 promotes colorectal carcinoma metastasis by upregulating ZEB1 transcriptional expression
    Luo, Chun-Ying
    Su, Wei-Chao
    Jiang, Hai-Feng
    Luo, Ling-Tao
    Shen, Dong-Yan
    Su, Guo-Qiang
    CANCER CELL INTERNATIONAL, 2023, 23 (01)
  • [22] ZEB1 promotes invasion and metastasis of endometrial cancer by interacting with HDGF and inducing its transcription
    Xiao, Yan-Yi
    Lin, Li
    Li, Yong-Hao
    Jiang, Hui-Ping
    Zhu, Li-Tong
    Deng, Yuan-Run
    Lin, Dan
    Chen, Wei
    Zeng, Cheng-Ying
    Wang, Li-Jing
    Chen, Shao-Cheng
    Jiang, Qing-Ping
    Liu, Chun-Hua
    Fang, Wei-Yi
    Guo, Sui-Qun
    AMERICAN JOURNAL OF CANCER RESEARCH, 2019, 9 (11): : 2314 - +
  • [23] ZEB1: New advances in fibrosis and cancer
    Cheng, Lin
    Zhou, Ming-Yuan
    Gu, Ying-Jian
    Chen, Lei
    Wang, Yun
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2021, 476 (04) : 1643 - 1650
  • [24] ZEB1 Expression Is Correlated With Tumor Metastasis and Reduced Prognosis of Breast Carcinoma in Asian Patients
    Xiang, Shuai
    Liu, Ya-Min
    Chen, Xu
    Wang, Ya-Wen
    Ma, Ran-Ran
    Wu, Xiao-Juan
    Gao, Peng
    CANCER INVESTIGATION, 2015, 33 (06) : 225 - 231
  • [25] USP43 directly regulates ZEB1 protein, mediating proliferation and metastasis of colorectal cancer
    Ye, Dao-xiong
    Wang, Si-si
    Huang, Ying
    Wang, Xiao-jie
    Chi, Pan
    JOURNAL OF CANCER, 2021, 12 (02): : 404 - 416
  • [26] LincRNA-ROR promotes invasion, metastasis and tumor growth in pancreatic cancer through activating ZEB1 pathway
    Zhan, Han-xiang
    Wang, Yao
    Li, Ce
    Xu, Jian-wei
    Zhou, Bin
    Zhu, Jian-kang
    Han, Hai-feng
    Wang, Lei
    Wang, Yun-shan
    Hu, San-yuan
    CANCER LETTERS, 2016, 374 (02) : 261 - 271
  • [27] Zeb1 is required for TrkB-induced epithelial-mesenchymal transition, anoikis resistance and metastasis
    Smit, M. A.
    Peeper, D. S.
    ONCOGENE, 2011, 30 (35) : 3735 - 3744
  • [28] RETRACTED: MicroRNA-200b acts as a tumor suppressor in osteosarcoma via targeting ZEB1 (Retracted Article)
    Li, Yusheng
    Zeng, Chao
    Tu, Min
    Jiang, Wei
    Dai, Zixun
    Hu, Yuling
    Deng, Zhenhan
    Xiao, Wenfeng
    ONCOTARGETS AND THERAPY, 2016, 9 : 3101 - 3111
  • [29] ZEB1 expression is a potential indicator of invasive endometriosis
    Furuya, Masataka
    Masuda, Hirotaka
    Hara, Kanako
    Uchida, Hiroshi
    Sato, Kenji
    Sato, Suguru
    Asada, Hironori
    Maruyama, Tetsuo
    Yoshimura, Yasunori
    Katabuchi, Hidetaka
    Tanaka, Mamoru
    Saya, Hideyuki
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2017, 96 (09) : 1128 - 1135
  • [30] The roles of ZEB1 in tumorigenic progression and epigenetic modifications
    Zhang, Yu
    Xu, Lei
    Li, Anqi
    Han, Xiuzhen
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 110 : 400 - 408